Medtronic (DE:2M6)

NYSE:2M6

2M6

Medtronic

RESEARCH TOOLSreports

Medtronic (2M6) Stock Forecast & Price Target

9 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

2M6 Analyst Ratings

Moderate Buy

13 Buy

8 Hold

0 Sell

Based on 21 analysts giving stock ratings to

Medtronic

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

2M6 Stock 12 Month Forecast

Average Price Target

€86.20

▲(17.15% Upside)

Based on 21 Wall Street analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is €86.20 with a high forecast of €105.66 and a low forecast of €70.44. The average price target represents a 17.15% change from the last price of €73.58.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"62":"€62","73":"€73","84":"€84","95":"€95","106":"€106"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":105.655194,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€105.66</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":86.19702910499998,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€86.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":70.436796,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€70.44</span>\n  </div></div>","useHTML":true}}],"tickPositions":[62,73,84,95,106],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,63.615,66.84886107692307,70.08272215384615,73.31658323076923,76.5504443076923,79.78430538461538,83.01816646153846,86.25202753846153,89.48588861538461,92.71974969230769,95.95361076923076,99.18747184615384,102.42133292307692,{"y":105.655194,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,63.615,65.35207916192307,67.08915832384615,68.82623748576923,70.5633166476923,72.30039580961538,74.03747497153846,75.77455413346154,77.51163329538461,79.24871245730768,80.98579161923075,82.72287078115383,84.45994994307691,{"y":86.19702910499998,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,63.615,64.13975353846153,64.66450707692307,65.18926061538461,65.71401415384615,66.23876769230769,66.76352123076923,67.28827476923077,67.8130283076923,68.33778184615385,68.86253538461538,69.38728892307692,69.91204246153846,{"y":70.436796,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":69.861,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.855,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 45,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.909,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.301,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.946,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.926,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.38,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.881,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.571,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.424,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.785,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.759,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.615,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€105.66

Average Price Target€86.20

Lowest Price Target€70.44

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Travis Steed

Bank of America Securities

€83.64

Buy

13.68%

Upside

Reiterated

06/25/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: CareDx (NASDAQ: CDNA) and Medtronic (NYSE: MDT)

Ryan Zimmerman

BTIG

€79.24

Buy

7.69%

Upside

Reiterated

06/22/26

BTIG Remains a Buy on Medtronic (MDT)

Michael Matson

Needham

€88.93

Buy

20.86%

Upside

Reiterated

06/17/26

Medtronic: Renal Denervation Momentum Supports Multi-Catalyst Growth Story; Buy Rating and $101 Price Target Reaffirmed

Matthew O'Brien

Piper Sandler

€74.84

Hold

1.71%

Upside

Reiterated

06/17/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: enGene Holdings (NASDAQ: ENGN), Medtronic (NYSE: MDT) and Roivant Sciences (NASDAQ: ROIV)

Larry Biegelsen

Wells Fargo

€89.81

Buy

22.05%

Upside

Reiterated

06/15/26

Analysts Offer Insights on Healthcare Companies: Odyssey Therapeutics, Inc. (NASDAQ: ODTX), Capricor Therapeutics (NASDAQ: CAPR) and Medtronic (NYSE: MDT)

Robbie Marcus

J.P. Morgan

€75.72

Hold

2.91%

Upside

Reiterated

06/05/26

J.P. Morgan Reaffirms Their Hold Rating on Medtronic (MDT)

Richard Newitter

Truist Financial

€83.64→€75.72

Hold

2.91%

Upside

Assigned

06/04/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Viatris (NASDAQ: VTRS), Medtronic (NYSE: MDT) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Priya Sachdeva

UBS

€79.24→€74.84

Hold

1.71%

Upside

Assigned

06/04/26

Medtronic price target lowered to $85 from $90 at UBSMedtronic price target lowered to $85 from $90 at UBS

David Rescott

Robert W. Baird

€81.88→€74.84

Hold

1.71%

Upside

Reiterated

06/04/26

Medtronic price target lowered to $85 from $93 at BairdMedtronic price target lowered to $85 from $93 at Baird

Vijay Kumar

Evercore ISI

€93.33

Buy

26.84%

Upside

Reiterated

06/04/26

Analysts Offer Insights on Healthcare Companies: Medtronic (NYSE: MDT), Arcus Biosciences (NYSE: RCUS) and Dyne Therapeutics (NASDAQ: DYN)

Josh Jennings

TD Cowen

€104.77

Buy

42.40%

Upside

Reiterated

06/04/26

TD Cowen Keeps Their Buy Rating on Medtronic (MDT)

David Roman

Goldman Sachs

€73.96→€73.08

Hold

-0.68%

Downside

Reiterated

06/04/26

Medtronic: Balanced Risk-Reward Keeps Hold Rating as Analyst Slightly Lowers Price Target to $83

Lee Hambright

Bernstein

€98.61→€85.4

Buy

16.07%

Upside

Reiterated

06/04/26

Medtronic: Buy Rating Reaffirmed as Strong Execution Offsets Sector Multiple Compression and Price Target Trim to $97

Anthony Petrone

Mizuho Securities

€105.66→€88.05

Buy

19.66%

Upside

Reiterated

06/03/26

Mizuho cuts Medtronic target, sees recent selloff as overdoneMizuho cuts Medtronic target, sees recent selloff as overdone

Joanne Wuensch

Citi

€96.85

Buy

31.63%

Upside

Reiterated

06/03/26

Analysts Offer Insights on Healthcare Companies: Vanda (NASDAQ: VNDA), ArriVent BioPharma, Inc. (NASDAQ: AVBP) and Medtronic (NYSE: MDT)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Travis Steed

Bank of America Securities

€83.64

Buy

13.68%

Upside

Reiterated

06/25/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: CareDx (NASDAQ: CDNA) and Medtronic (NYSE: MDT)

Ryan Zimmerman

BTIG

€79.24

Buy

7.69%

Upside

Reiterated

06/22/26

BTIG Remains a Buy on Medtronic (MDT)

Michael Matson

Needham

€88.93

Buy

20.86%

Upside

Reiterated

06/17/26

Medtronic: Renal Denervation Momentum Supports Multi-Catalyst Growth Story; Buy Rating and $101 Price Target Reaffirmed

Matthew O'Brien

Piper Sandler

€74.84

Hold

1.71%

Upside

Reiterated

06/17/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: enGene Holdings (NASDAQ: ENGN), Medtronic (NYSE: MDT) and Roivant Sciences (NASDAQ: ROIV)

Larry Biegelsen

Wells Fargo

€89.81

Buy

22.05%

Upside

Reiterated

06/15/26

Analysts Offer Insights on Healthcare Companies: Odyssey Therapeutics, Inc. (NASDAQ: ODTX), Capricor Therapeutics (NASDAQ: CAPR) and Medtronic (NYSE: MDT)

Robbie Marcus

J.P. Morgan

€75.72

Hold

2.91%

Upside

Reiterated

06/05/26

J.P. Morgan Reaffirms Their Hold Rating on Medtronic (MDT)

Richard Newitter

Truist Financial

€83.64→€75.72

Hold

2.91%

Upside

Assigned

06/04/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Viatris (NASDAQ: VTRS), Medtronic (NYSE: MDT) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Priya Sachdeva

UBS

€79.24→€74.84

Hold

1.71%

Upside

Assigned

06/04/26

Medtronic price target lowered to $85 from $90 at UBSMedtronic price target lowered to $85 from $90 at UBS

David Rescott

Robert W. Baird

€81.88→€74.84

Hold

1.71%

Upside

Reiterated

06/04/26

Medtronic price target lowered to $85 from $93 at BairdMedtronic price target lowered to $85 from $93 at Baird

Vijay Kumar

Evercore ISI

€93.33

Buy

26.84%

Upside

Reiterated

06/04/26

Analysts Offer Insights on Healthcare Companies: Medtronic (NYSE: MDT), Arcus Biosciences (NYSE: RCUS) and Dyne Therapeutics (NASDAQ: DYN)

Josh Jennings

TD Cowen

€104.77

Buy

42.40%

Upside

Reiterated

06/04/26

TD Cowen Keeps Their Buy Rating on Medtronic (MDT)

David Roman

Goldman Sachs

€73.96→€73.08

Hold

-0.68%

Downside

Reiterated

06/04/26

Medtronic: Balanced Risk-Reward Keeps Hold Rating as Analyst Slightly Lowers Price Target to $83

Lee Hambright

Bernstein

€98.61→€85.4

Buy

16.07%

Upside

Reiterated

06/04/26

Medtronic: Buy Rating Reaffirmed as Strong Execution Offsets Sector Multiple Compression and Price Target Trim to $97

Anthony Petrone

Mizuho Securities

€105.66→€88.05

Buy

19.66%

Upside

Reiterated

06/03/26

Mizuho cuts Medtronic target, sees recent selloff as overdoneMizuho cuts Medtronic target, sees recent selloff as overdone

Joanne Wuensch

Citi

€96.85

Buy

31.63%

Upside

Reiterated

06/03/26

Analysts Offer Insights on Healthcare Companies: Vanda (NASDAQ: VNDA), ArriVent BioPharma, Inc. (NASDAQ: AVBP) and Medtronic (NYSE: MDT)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medtronic

3 Months

Anthony PetroneMizuho Securities

Success Rate

18/25 ratings generated profit

Average Return

+2.95%

Copying Anthony Petrone's trades and holding each position for 3 Months would result in 72.00% of your transactions generating a profit, with an average return of +2.95% per trade.

1 Year

Anthony PetroneMizuho Securities

Success Rate

16/25 ratings generated profit

Average Return

+0.08%

Copying Anthony Petrone's trades and holding each position for 1 Year would result in 64.00% of your transactions generating a profit, with an average return of +0.08% per trade.

2 Years

Anthony PetroneMizuho Securities

Success Rate

14/25 ratings generated profit

Average Return

+1.84%

Copying Anthony Petrone's trades and holding each position for 2 Years would result in 56.00% of your transactions generating a profit, with an average return of +1.84% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2M6 Analyst Recommendation Trends

Rating

Feb 26

Mar 26

Apr 26

May 26

Jun 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 2M6 has received 32 Buy Ratings, 17 Hold Ratings, and 0 Sell Ratings. 2M6 average Analyst price target in the past 3 months is 86.20.

Each month's total comprises the sum of three months' worth of ratings.

2M6 Financial Forecast

2M6 Earnings Forecast

Next quarter’s earnings estimate for 2M6 is €1.21 with a range of €1.20 to €1.23. The previous quarter’s EPS was €1.35. 2M6 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 2M6 has Performed in-line its overall industry.

2M6 Sales Forecast

Next quarter’s sales forecast for 2M6 is €8.34B with a range of €8.30B to €8.43B. The previous quarter’s sales results were €8.56B. 2M6 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 2M6 has Performed in-line its overall industry.

2M6 Stock Forecast FAQ

What is DE:2M6’s average 12-month price target, according to analysts?

Based on analyst ratings, Medtronic’s 12-month average price target is 86.20.

What is DE:2M6’s upside potential, based on the analysts’ average price target?

Medtronic has 17.15% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Medtronic a Buy, Sell or Hold?

Medtronic has a consensus rating of Moderate Buy, which is based on 13 buy ratings, 8 hold ratings and 0 sell ratings.

What is Medtronic’s share price target?

The average share price target for Medtronic is 86.20. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €105.66 ,and the lowest forecast is €70.44. The average share price target represents 17.15% Increase from the current price of €73.58.

What do analysts say about Medtronic?

Medtronic’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 21 Wall Streets Analysts.

How can I buy shares of Medtronic?

To buy shares of DE:2M6, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Medtronic (2M6) Stock Forecast & Price Target

2M6 Analyst Ratings

2M6 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Medtronic

2M6 Analyst Recommendation Trends

2M6 Financial Forecast

2M6 Earnings Forecast

2M6 Sales Forecast

2M6 Stock Forecast FAQ

Detailed List of Analyst Forecasts